In this free webinar, hosted by DDW and sponsored by Bio-Rad, you will learn about the innovation taking place within the therapeutic antibody sector and what the current opportunities and challenges are for drug developers in the industry.  

The webinar will take place on Thursday 27 March at 3PM GMT/11AM EDT. 

You will hear from Aron Knickerbocker, CEO of Aulos Bioscience, and Martin Brenner, CEO of iBio. 

You will learn about: 

• The drivers and challenges in therapeutic antibody discovery
• How and where are we seeing innovation and evolution?
• The impact of antibody engineering
• The potential of antibody-drug conjugates for treating disease

A Q&A session follows the webinar presentations.

Register for free now to secure your place!